Published in

Springer, Cancer Immunology, Immunotherapy, 7(66), p. 913-926, 2017

DOI: 10.1007/s00262-017-1995-x

Links

Tools

Export citation

Search in Google Scholar

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO